Literature DB >> 24090940

Liver abnormalities in bowel diseases.

Martin Kummen1, Erik Schrumpf, Kirsten Muri Boberg.   

Abstract

Liver abnormalities are often seen in bowel diseases. Whether these represent aspects of two separate diseases, or if one is causing the other, is not always easy to decide. Extraintestinal manifestations of inflammatory bowel disease (IBD) or coeliac disease are frequently observed. Of these extraintestinal manifestations, hepatic disorders are among the most common. Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis are the most frequent hepatic disorders in IBD and coeliac disease, respectively. Genetic studies have lately elucidated the associations between IBD and PSC, but there is still a long way until we have complete understanding of the molecular aetiology and pathophysiology of these conditions. There is no curative treatment available for PSC, besides liver transplantation. Steatosis and cholelithiasis are also common in IBD, as are signs of hepatic injury due to IBD treatment. Less common liver abnormalities include liver abscesses, hepatic thromboembolic events, granulomatous liver disease and hepatic amyloidosis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biliary tract disease; Celiac disease; Inflammatory bowel disease; Liver disease; Primary sclerosing cholangitis

Mesh:

Year:  2013        PMID: 24090940     DOI: 10.1016/j.bpg.2013.06.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

Review 1.  Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

Authors:  Katharina Brandl; Bernd Schnabl
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-06-18       Impact factor: 3.869

2.  The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation.

Authors:  Elisabeth Schrumpf; Martin Kummen; Laura Valestrand; Thomas U Greiner; Kristian Holm; Velmurugesan Arulampalam; Henrik M Reims; John Baines; Fredrik Bäckhed; Tom H Karlsen; Richard S Blumberg; Johannes R Hov; Espen Melum
Journal:  J Hepatol       Date:  2016-10-05       Impact factor: 25.083

Review 3.  Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?

Authors:  Atsushi Tanaka; Joachim C Mertens
Journal:  Inflamm Intest Dis       Date:  2016-04-01

Review 4.  Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied.

Authors:  Rui-Dong Duan
Journal:  World J Hepatol       Date:  2018-02-27

5.  Analysis of the disease activity of ulcerative colitis with and without concomitant primary sclerosing cholangitis: An investigation using a nationwide database in Japan.

Authors:  Kota Yano; Rintaro Moroi; Hisashi Shiga; Kunio Tarasawa; Yusuke Shimoyama; Masatake Kuroha; Shin Hamada; Yoichi Kakuta; Kiyohide Fushimi; Kenji Fujimori; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  JGH Open       Date:  2021-12-28

6.  Hepatobiliary phenotype of individuals with chronic intestinal disorders.

Authors:  Jessica Voss; Carolin V Schneider; Moritz Kleinjans; Tony Bruns; Christian Trautwein; Pavel Strnad
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

7.  Polysaccharides from Garlic Protect against Liver Injury in DSS-Induced Inflammatory Bowel Disease of Mice via Suppressing Pyroptosis and Oxidative Damage.

Authors:  Xinyi Zhan; Weijie Peng; Zhuqiang Wang; Xin Liu; Weibo Dai; Quanxi Mei; Xianjing Hu
Journal:  Oxid Med Cell Longev       Date:  2022-08-16       Impact factor: 7.310

8.  Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography.

Authors:  Rui-Dong Duan; Ulf Hindorf; Yajun Cheng; Per Bergenzaun; Mats Hall; Erik Hertervig; Åke Nilsson
Journal:  BMC Gastroenterol       Date:  2014-08-07       Impact factor: 3.067

Review 9.  Liver manifestations and complications in inflammatory bowel disease: A review.

Authors:  Rui Gaspar; Catarina Castelo Branco; Guilherme Macedo
Journal:  World J Hepatol       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.